Vaccine News and Research

Latest Vaccine News and Research

Drugmakers tout COVID-19 vaccines to refurbish their public image

Johnson & Johnson researchers working on a vaccine against the coronavirus are "just like the heroes in the hospitals" fighting to save patients, J&J CEO Alex Gorsky said on the "Today" show a few weeks ago.

18 May 2020

People infected with hepatitis D are more prone to hepatocellular carcinoma

Of all the hepatitis viruses, D is the most poorly known.This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.

From Avacta Life Sciences Ltd. 18 May 2020

COVID-19 clinical trials show positive early results, says GlobalData

With the number of COVID-19 cases and deaths increasing with each passing day, the need for a therapeutic or a vaccine for the pandemic intensifies.

18 May 2020

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.

18 May 2020

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

As the world continues to grapple with the coronavirus pandemic, many scientists, institutions, and pharmaceutical companies are working hard to develop an effective vaccine.

18 May 2020

Staggered local re-openings could be the best COVID-19 exit strategy

When a new infectious disease appears, the lack of an effective treatment or vaccine strategy often results in the application of non-pharmacological interventions (NPIs) or containment measures, including testing for infection, tracing contacts, and isolating potential sources of infection.

17 May 2020

Inadequate vaccine and epidemic control in the US

A new paper published on the preprint server medRxiv* in May 2020 shows that vaccination must be combined with nonpharmacological interventions (NPIs) to achieve rapid and effective control of the ongoing pandemic.

17 May 2020

Researchers investigate safety of convalescent plasma for COVID-19

The current pandemic of COVID-19 seems to be slowing down in various parts of the world, but is far from controlled, as incidence rates rise in new regions. In the absence of an effective vaccine or therapeutic drug, scientists have relied on supportive medical care to treat the sick.

17 May 2020

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

US researchers have published a proof of concept on the efficacy of human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in laboratory conditions, as well as their pioneering use in a mouse model. The study is available on the preprint server bioRxiv*.

17 May 2020

New algorithm could help investigate the genetic clues behind immunity

Scientists with UC San Diego's Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients - information that is key to creating a versatile and effective vaccine.

15 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

The Networks of Centres of Excellence recently announced its continued support in Canadian glycomics research with a three-year investment of $16.3 million through the Canadian Glycomics Network (GlycoNet).

15 May 2020

A measured approach to relaxation of COVID-19 lockdown measures may be necessary

A cautious, measured approach to relaxation of lockdown measures is required to protect the most vulnerable members of society and support the health service, a team of infectious disease experts from the University of Warwick, who have investigated the impact of current lockdown measures upon the spread of COVID-19 in the UK, has found.

15 May 2020

Vaccine News and Research

Latest Vaccine News and Research

Drugmakers tout COVID-19 vaccines to refurbish their public image

People infected with hepatitis D are more prone to hepatocellular carcinoma

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

COVID-19 clinical trials show positive early results, says GlobalData

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Staggered local re-openings could be the best COVID-19 exit strategy

Inadequate vaccine and epidemic control in the US

Researchers investigate safety of convalescent plasma for COVID-19

Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2

New algorithm could help investigate the genetic clues behind immunity

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Canadian Glycomics Network welcomes $16.3 million renewed funding from NCE

A measured approach to relaxation of COVID-19 lockdown measures may be necessary

Media representations are changing to reflect new public attitudes toward autism

Chasing the elusive dream of a COVID cure

First cellular immunology data to help guide social distancing recommendations

HVTN and HPTN initiate first clinical trial in response to COVID-19

Research investigates COVID-19 virus origin using artificial intelligence (AI)

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in